The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of durvalumab following trimodality therapy for locally advanced esophageal and GEJ adenocarcinoma: Early efficacy results from Big Ten Cancer Research Consortium study.
 
Hirva Mamdani
Consulting or Advisory Role - Tempus
 
Bryan J. Schneider
Consulting or Advisory Role - Genentech/Roche
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Macrogenics (Inst); MedImmune (Inst); OncoMed (Inst)
 
Laith I. Abushahin
No Relationships to Disclose
 
Thomas J Birdas
No Relationships to Disclose
 
Kenneth Kesler
No Relationships to Disclose
 
Ahran Lee
No Relationships to Disclose
 
Heather Burney
No Relationships to Disclose
 
Susan Perkins
No Relationships to Disclose
 
Shadia Ibrahim Jalal
Research Funding - AstraZeneca/MedImmune